UBS maintains Bath & Body Works at Neutral, raises price target to $22 from $17
UBS kept its Neutral rating on Bath & Body Works but increased its price target to $22 from $17, suggesting a 4.4% upside from the Nov 12 close of $21.08. The new target represents a 29.4% increase.
How this was made

The 30-second read
Why it matters
The higher target could trigger buying from investors following UBS's guidance.
Market read
Analyst target raise may influence short-term price action for BBWI.
What to watch
Potential supply chain constraints and competitive pressure are not addressed.
Background
UBS maintains a neutral rating but upgrades the price target, implying confidence in future earnings.
Ticker impact
UBS raised its price target for Bath & Body Works to $22 from $17, indicating a new bullish outlook.
likely upward pressure as traders price in the higher target
Analyst upgrades often lead to short-term buying, especially when the new target is above the current price.
Market effects
May lift sentiment for the consumer discretionary sector.
US retail stocks could see modest gains.
Limited to US markets.
Counterpoint
The target raise may be premature if sales momentum stalls.
Key entities
- companyBath & Body Works
US-listed retailer of personal care products.
- analystUBS
Financial services firm providing the rating and target.



